Next Article in Journal
Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
Next Article in Special Issue
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
Previous Article in Journal
Suppression of Intracellular Reactive Oxygen Species in Human Corneal Epithelial Cells via the Combination of Quercetin Nanoparticles and Epigallocatechin Gallate and In Situ Thermosensitive Gel Formulation for Ocular Drug Delivery
Previous Article in Special Issue
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(7), 680; https://doi.org/10.3390/ph14070680
Action Date Notes Link
article xml file uploaded 15 July 2021 17:57 CEST Original file -
article xml uploaded. 15 July 2021 17:57 CEST Update https://www.mdpi.com/1424-8247/14/7/680/xml
article pdf uploaded. 15 July 2021 17:57 CEST Version of Record https://www.mdpi.com/1424-8247/14/7/680/pdf
article supplementary file uploaded. 15 July 2021 17:57 CEST - https://www.mdpi.com/1424-8247/14/7/680#supplementary
article html file updated 15 July 2021 17:58 CEST Original file -
article html file updated 27 July 2022 05:04 CEST Update https://www.mdpi.com/1424-8247/14/7/680/html
Back to TopTop